of Al, and subsequently of Al-D1 and Al-D4, were then isolated as described elsewhere (4). The preparations were either dialyzed at 4" directly into the solvents used in the experiments or against distilled water and lyophilized.
Column
Chromatography-Gels for column chromatography were obtained from Pharmacia Fine Chemicals. Analytical Sepharose 2B and 6B columns (141 X 0.8 cm) were eluted with 0.5 M sodium acetate, pH 7. The flow rates were 4 ml per hour, and 1.3-to 1.4.ml fractions were collected.
A preparative Sepharose 2B column (163 X 4 cm) was eluted with the same solvent. The flow rate was 35 ml per hour, and 20.ml fractions were collected.
The eluting solvent was boiled before use. A Sephadex G-200 column (140 X 1.3 cm) was eluted with 4 M GuHCl (4). The flow rate was 4 ml per hour, and 3-ml fractions were collected. All columns were run at 18". Acid-Stock solutions of nasal and tracheal Al-D1 and of the hyaluronic acid samples were made in 0.5 M GuHCl. Aliquots, 100 kl, of different dilutions of the hyaluronic acid solutions were added to 1.5-ml aliquots of proteoglycan solutions of two different concentrations.
The final mixtures contained either 2.22 or 0.71 mg per ml of proteoglycan, and rat)ios of hyaluronic acid to proteoglycan between 0.4 and 7% (w/w).
The hyaluronic acid concentrations were estimated from hexuronic acid analyses of stock solutions and a theoretical value 0.40 for the hexuronic acid content (calculated as lactone) of the guanidinium salt of hyaluronic acid.
The mixtures were kept at 20" for 10 to 16 hours before measuring their viscosities.
Proteolysis of Proteoglycans-Lgophilized proteoglvcan samples _ were dissolved overnight in 0.5 M sodium acetate, 0.i M K,HPOd, 0.01 M sodium EDTA, nH 6.5 (8 me oer ml).
Aliauots of a oaoain _ Y_ I I suspension were activated for 30 min in 10 volumes of the same solvent at 37" after the addition of freshly dissolved cysteine to 0.01 M. Cysteine was added to the proteoglycan solutions to 0.01 M, and activated papain (about 10 rg per mg of proteoglycan) was added.
In one experiment, after various incubation times at 37", l-ml aliquots of a digest of nasal Al were treated with iodoacetic acid (final concentration, 0.04 M) to inactivate the papain.
Samples were stored at -30" until they were chromatographed on Sepharose 2B or 6B analytical columns. Samples of powdered nasal and tracheal cartilage, 100 mg each, were suspended in l-ml aliquots of buffer and digested with approximately 100 pg of activated papain for 2 hours at 37" as described above.
The digests were centrifuged at 4" in a Sorvall SS-34 rotor for 15 min at 15,000 rpm.
The clear supernatants were chromatographed on Sepharose 2B. An aliquot of nasal Al in 0.1 M Tris, 0.001 M CaCl2, pH 7.2 (7 4234 mg per ml), was digested for 2 hours at 37" with 100 rg of trypsin. The digest was chromatographed on Sepharose 2B.
Isolation of Hyaluronic
Acid and Bound Proteins-A papain digest of 600 mg of nasal Al in 40 ml was made at 37" for 2 hours as described above.
The digest was concentrated to 15 ml by ultrafiltration at 4" with an Amicon PM-10 filter, and then applied to the preparative Sepharose 2B column. The large protein peak indicated in Fig. 5a below (Al-P-2B) was uooled. ultra-?iltered at 4' with an-Amicon PM-10 memdrane t; a volume of about 50 ml, desalted by ultrafiltration with 15 volumes of water, and lyophilized.
Approximately 20 mg were recovered. A total of 18 mg of Al-P-2B was dissolved in 1 ml of 4 M GuHCl and chromatographed in two 0.5-ml aliquots on Sephadex G-200 with 4 M GuHCl as the eluent.
The absorbances at 280 nm and the hexuronic acid contents of the fractions were determined. The two peaks shown in Fig. 5b below were pooled as indicated. The first (Al-P-2B-G200-1) was dialyzed at 4" against water and lyophilized, yielding 2.8 mg. The second (Al-P-2B-G200-2) was ultrafiltered to about 10 ml with an Amicon UM-05 membrane, desalted by ultrafiltration with 15 volumes of water, and lyophilized, yielding 12 mg. The Al-P-2B-G200-1 was analyzed for its content of hexuronic acid and hexosamines.
It was then redigested with papain for 5 hours at 37" and chromatographed on an analytical Sepharose 6B column.
After hexuronic acid analyses of the effluent, Fractions 1 and 2 were separately pooled as indicated in Fig. 5c , dialyzed against water, and lyophilized.
Hexuronic acid and hexosamine contents of each were determined.
Aliquots of Fraction 1 in 0.1 M sodium acetate, 0.15 M NaCl, pH 5.0 (about 50 rg/50 J), were fractionated on cetylpyridinium chloride-cellulose microcolumns by the procedure of Antonopoulos et al. (22) before and after treatment with about 5 pg of testicular hyaluronidase, 20 hours, 37". Samples of HA, were carried through the same procedure for comparison.
Fractions from the microcolumns were analyzed for hexuronic acid.
In a buffer blank, a small amount of nonspecific carbazole reactivity was observed in the 6 M HCl elution step. The sample columns were corrected for this background.
Portions of Al-P-2B-G200-2 were dissolved in 4 M GiHCl (300 or 600 &30 ~1) and then diluted with 0.5 ml of 0.5 M sodium ace--.
tate, pH 6.5,'in the presence or absence of 50 pg of HA, or of HAb. After 2 hours at room temperature, the samples were chromatographed on an analytical Sepharose 2B column. Portions (approximately 25 rg) of the Al-P-2B-G200-2 were subjected to electrophoresis on SDS-pol.yacrylamide gels as described above, as were samples of nasal Al-64 for comparison.
Treatment of Proteoalucans with Chondroitinase-Proteoelvcan samples were 'dissolve; -in 0.1 M sodium acetate, 0.1 M T&i pH 7.3 (8 mg per ml), and digested at 37" with chondroitinase ABC. The progress of the digestion was monitored with a modification of the periodic acid-thiobarbituric acid procedure (17).6 The concentration of Reagent 2 was lowered from 3 to 2% NaAsOz in 0.5 M HCl. and the neriodic acid oxidation was stormed bv addine 0.75 ml of this reagent rather than 0.5 ml.
Th;s' mo&fication prevents the formation of a precipitate which can occur after the heating step in the original procedure. Two concentrations of chondroitinase were used, either 0.025 unit per mg of proteoglycan for 25 min or 0.05 unit per mg of proteoglycan for periods of time between 0.5 and 20 hours.
In the first digestion, the incubation time was selected such that 80% of the hexuronic acid residues were converted to the digest,ion product.
For the second set of conditions, the digestion was 95 to 100% complete for all time points.
Portions of some of the digests were dialyzed at 4" against 0.5 M sodium acetate, 0.1 M K2HPOa, 0.01 M sodium EDTA, pH 6.5. Samples were then chromatographed on Sepharose 2B or 6B either directly or after treatment with papain for 2 hours as described above.
The samnles were stored at -30" until chromatographed.
In a similar experiment, a sample of nasal Al was dissolved in 0.15 M NaCl, 0.1 M sodium acetate, pH 5.0 (8 mg in 1 ml). Highly purified testicular hyaluronidase (100 yg) was added. and the solution was incubated at 37" for 3 hours. After the addition of sodium EDTA and cysteine to 0.01 M each, the sample was digested with papain and subsequently chromatographed on Sepharose 6B. Analyses of centrifugal patterns such as those in Fig. 2, a, d to f, indicated that the monomer and aggregate peaks had so values of about 25 and 93 S for nasal Al and 24 and 43 S for the tracheal Al.
Analyses of the areas under the peaks in the schlieren patterns showed that about SOY, of both samples were aggregated (78 and 8270 for tracheal Al and nasal Al, respectively).
Thus, the viscosimetric and centrifugal data suggest that the aggregates in nasal Al are much larger than those in tracheal Al although about the same proportion of proteoglycan molecules in each preparation are aggregated. Treatment of Proteoglycans with Proteases-Samples of nasal Al and nasal Al-D1
were treated with papain at 37" for 2 hours, and the digests were chromatographed on Sepharose 673. The results of protein and hexuronic acid analyses of the column fractions are shown in Fig. 3 . The large hexuronic acid peak in each chromatogram indicates the elution profile for the chondroitin sulfate chains released by the papain. For nasal Al slightly less than 1% of the total hexuronic acid was recovered in the excluded volume (shaded peak) along with a large amount of protein.
For nasal Al-Dl, this excluded peak was absent. Subsequently, identical aliquots of nasal Al were digested with papain at 37" for different lengths of time, and the digests were chromatographed on Sepharose 2B. The analyses for the 2-hour digest, Fig. 4b , indicate that the protein peak, which eluted in the void volume on Sepharose 6B, eluted from Sepharose 2B as a broad peak distributed through the column volume. The area under this peak decreased significantly as the digestion time was increased, Fig. 4a , but its elution position on t'he column was unchanged. This indicates that the sizes of the molecules in the peak were not altered appreciably by the proteolysis although protein was being removed. Papain digestion for 2 hours at 50" completely abolished the peak. See text for details.
cates that the protein peak was also present in trypsin digests of nasal Al. However, the hexuronic acid analysis in Fig. 4c indicates that the chondroitin sulfate fragments released by trypsin are much larger than those released by papain (24). Although the protein peak was present in a chromatographic analysis of a papain digest of tracheal Al, Fig. 4d , it was much more retarded than that for nasal Al and hence of smaller size. Under relatively mild conditions, then, proteolysis of proteoglycan preparations which contain aggregates can remove the polysaccharide portions of the proteoglycans while leaving peptidic material bound to large, protease-resistant macromolecules. The difference in the sizes of this component for nasal and tracheal Al-P preparations may correlate with the difference in the sizes of the aggregates observed in the centrifugal analyses of the respective Al preparations. Al-P-2B was recovered in the excluded volume of the column (Al-P-2B-G200-l), whereas almost all of the protein, indicated by the 280-nm absorbance, was recovered within the column (Al-P-2B-G200-2).
The hexuronic acid content of the Al-P-2B-G200-1 fraction was somewhat greater than its hexosamine Values are given as molar ratio to hexuronic acid and, within brackets, the relative per cent of total hexosamine.
Glucosamine Galactosamine
Al-P-2B-G200-la 0.67 (86) 0.11 (14) Al-P-2B-G200-I-P-6Bl 0.80 (95) 0.04 (5) Al-P-2B-G200-l-P-6B2 0.61 (68) 0.29 (32) a Hexuronic acid accounted for 25Yc of the dry weight. Table I . An infrared analysis of this fraction indicated that its content of sulfate ester was very 10w.~
The hexosamine analysis of Al-P-2B-G200-1, done with an amino acid analyzer, revealed the presence of 5 to 10% amino acids.
Therefore, this fraction was redigested with papain and chromatographed on Sepharose 6B, Fig. 5c . The largest peak (A1-P-2B-G200-1-P-6B1) contained hexuronic acid and glucosamine as its major constituents, with glucosamine accounting for more than 95% of the total hexosamines, Table I . Samples of this fraction and of HA, were analyzed for their glycosaminoglycan profiles on cetylpyridinium chloride-cellulose microcolumns before and after treatment with testicular hyaluronidase. The analyses, shown in Table II, are characteristic of hyaluronic acid (22).
Most of the undigested samples were eluted from the columns with 0.3 M NaCl, and the hyaluronidase treatment produced digestion products which were too small to precipitate on the column.
The minor, retarded peak (Al-P-2B-G200-l-P-6B2) contained a higher proportion of galactosamine than the first peak, Table  I . It eluted in a region of the column where chondroitin sulfate and keratan sulfate chains would elute, and it probably contained a mixture of several types of glycosaminoglycans.
In sum the analyses indicate that the Al-P-2B-G200-1 fraction consists of about 80% hyaluronic acid. Since about 3 mg were recovered in this fraction from a digest of 600 mg of nasal Al, the Al preparation would contain at least 0.4% hyaluronic acid.
The hexuronic acid analysis in Fig. 3a 423'7 about 80% of nasal Al (2), the actual amount of hyaluronic acid in Al would be leas than 0.8%.
Analyses of Al-P-2B-G200-2
Fro&on-Chemical analyses for Al-P-2B-G200-2 indicate that this fraction is predominantly protein, Table III . No hexosamines were detected. Its amino acid composition was more similar to that of glycoprotein link (Al-D4) preparations than to that of proteoglycan subunit (Al-Dl) preparations (2, 4, 25), as indicated by its relatively higher aspartic acid (asparagine) and arginine and relatively lower serine, glycine, and proline contents.
Aliquots of Al-P-2B-G200-2 were subjected to electrophoresis on SDS-polyacrylamide gels, Fig. 6 . Two major bands, c and d, were observed before (Gel 1), and a series of much smaller peptides were seen after (Gel .%'), reduction of disulfide bonds with &mercaptoethanol. For comparison, samples of nasal Al-D4 were treated the same way, Gels S and 4. Two major protein bands, a and b, were observed within the gel, as has been described previously for a similar preparation (7). Beduction of disulfide bonds decreased the mobility of these proteins in the gel to positions a' and b'. In the same system, reduced ovalbumin (43,000 mol wt) and reduced bovine serum albumin (67,000 mol wt) migrated in identical gels to the positions indicated by the arrows. The data suggest that Components a' and b' have molecular weights of about 40,000 and 50,000, respectively. The position of Band c in Al-P-2B-G200-2 is very close to that of Band a in Al-D4. This suggests that Component c may be derived from Component a after some peptide bonds within the latter are hydrolyzed by the papain. No band was found in Al-P-2B-G200-2 that would correspond to Component b which suggests that Component b in the original Al preparation was susceptible to the proteolytic treatment. There is no band in the Al-D4 analysis which would correspond directly with Component d which has a molecular weight (about 65,000) that is greater than Components a and b. Evidence is presented in a separate paper which indicates that this component is derived from that portion of the protein in proteoglycan molecules which binds to hyaluronic acid (26).
The Sephadex G-200 analysis, Fig. 5b , indicated that the proteins in Al-P-2B were associated with hyaluronic acid through noncovalent interactions, and experiments discussed below indicate that they retain their ability to bind with hyaluronic acid. The fact that such large protein moieties can survive treatment with papain suggests that their interactions with hyaluronic acid stabilize their structure and partially protect them from proteolysis. Further, 5 to 6 times as much protein (w/w) as hyaluronic acid was recovered from the Sephadex G-200. This suggests that the hyaluronic acid molecules in the Al aggregates may be surrounded effectively by a protein shell as is also suggested by the experiments with chondroitinase discussed below.
Viscosimetric Analyses of Mixtures of Hyaluronic Acid with
Al-D1--Hexuronic acid analyses of Sepharose 2B chromatograms of high molecular weight HA, from rooster comb and of low molecular weight HAb from human umbilical cord are shown The values which nasal Al and tracheal Al would have at the same solute concentrations (estimated from data in Fig. 1 ) are indicated.
in Fig. 7 was used in the esperiments described for Fig. 8 , the increases in viscosity for the mixtures with hyaluronic acid were 5 to 10% less than for nasal Al-Dl.
Otherwise the results were the same.
This supports the suggestion above that the Al-D1 preparations from these two tissues have very similar properties.
The viscosities of the HAs mixtures with Al-D1 were close to those that tracheal Al would have at the same solute concentrations, Fig. 8 . Further, the elution profile of HAs on Sepharose 2B, Fig. 7 , was nearly the same as that of the hyaluronic acid-protein complex in the chromatogram of papain digested tracheal Al, Fig. 4d . If the elution position of this latter peak indicates the relative size of the hyaluronic acid molecules in the papain digest, these results are consistent with the suggestion that aggregate sizes in Al preparations are determined by the sizes of the hyaluronic acid molecules. Interaction of Al-P-2B-GZOO-2 Proteins with Hyaluronic AcidSamples of Al-P-2B-G200-2 were dissolved in small aliquots of 4 M GuHCl, as they did not readily dissolve in 0.5 M salt solutions. Solutions with or without hyaluronic acid were prepared and chromatographed on Sepharose 2B as described under "Experimental Procedures."
In the absence of hyaluronic acid, Folin reactivity was observed only in the column total volume where a large peak, primarily due to the guanidinium ion, appeared, Fig. 9a . At a ratio of Al-P-2B-G200-2 to hyaluronic acid of 6 (w/w), mixtures with HA, and HAb gave the elution profiles shown in Fig. 9 , b and c, respectively.
The excluded protein peak from the HA, mixture was isolated; electrophoresis of the unreduced sample on a SDS-polyacrylamide gel showed that both protein components (c and d of Gel 1, Fig. 6 ) were present. The protein peak for the HAb mixture eluted at a position only slightly less retarded than HAb alone (compare Fig. 9c with 76) . The chromatogram in Fig. 9d indicates that the hyaluronic acid was not saturated since the addition of twice as much Al-P-2B-G200-2 to the HAb gave a slightly less retarded peak with about twice as much Folin reactivity. The hyaluronic acid molecules, then, can bind large amounts of the Al-P-BB-G200-2 proteins without appreciably altering the chromatographic behavior of the polysaccharide.
Analyses of Papain Digests of Nasal and Tracheal CartilageAliquots of clarified papain digests of nasal and tracheal cartilage samples were chromatographed on Sepharose 2B. The protein elution profiles observed, Fig. 10 , were very similar to those of papain digests of the Al preparations obtained from the same tissues, Fig. 4, b and d . Further, the amounts of cartilage digested, 100 mg, would normally yield 8 to 10 mg of Al, the amounts used in the experiments in Fig. 4 . When the indicated peaks were isolated, and unreduced samples were subjected to on Sepharose 6B. The small protein peak in b was present in a control which contained only the enzyme solution.
The procedures for preparing
Al use a dissociative solvent in the extraction process and then dialysis to a lower ionic strength where the molecules reassociate.
It is not known whether this reassociation yields aggregates which are organized in the same way as they were in the intact tissue.
However, the experiments described here suggest that many of the characteristics of the aggregates in Al, such as their size, and the type of proteins bound to hyaluronic acid, are a reflection of how these macromolecules are probably organized in vivo. Treatment of Proteoglycans with Chondroitinase ABC-After digestion of nasal Al with chondroitinase, two peaks were observed in the analytical centrifuge (17). The more rapidly sedimenting one was not observed in digests of nasal Al-Dl. The results suggested that the aggregates were stable to treatment with chondroitinase enzymes. This is somewhat surprising because these enzymes can digest hyaluronic acid (10). Figs. 11 to 13 show the results of some experiments designed to study this problem more systematically.
Sepharose 2B and 6B chromatograms of dialyzed chondroitinase digests of nasal Al-D1 showed in each case a single, included peak, Fig. 11, a and b . A Sepharose 6B chromatogram of a papain digest of chondroitinase-treated Al-D1 showed only one well retarded peak that eluted before the column total volume, Fig. 11~ . This peak was primarily anthrone-reactive, which indicates that it contained mainly keratan sulfate fragments.
A sample of nasal Al was treated with chondroitinase until 80% of the hexuronic acid residues were digested. 12. The graphs show analyses for aliquots of nasal Al which were treated with chondroitinase (0.025 unit per mg of proteoglycan, 20 min for CBr or 0.05 unit per mg of prot,eoglycan, 4 hours for CBZ), then dialyzed, and either chromatographed directly on Sepharose 2B (a and b), or digested with papain and chromatographed on Sepharose 2B (c). Fig. 12~ . About 90% of the protein, 80% of the remaining hexuronic acid and 80 y0 of the neutral sugar reactivity chromatographed in or immediately after the void volume. Therefore, most of the molecules were still bound into large aggregate structures even though most of the chondroitin sulfate in the Al was removed by the enzyme. Fig. 12b shows the results of a similar experiment in which a much more extensive chondroitinase digestion was used. The aggregate structures were reduced greatly in size although they were still larger than the molecules in the similar digest of Al-Dl, Fig. 11~ . The differences in the analyses for the two chondroitinase treatments of Al suggest that the enzyme can slowly hydrolyze the hyaluronic acid in the Al preparation.
The following experiments support this suggestion. A sample from the partial chondroitinase digest of Al was treated with papain and then chromatographed on Sepharose 2B, Fig. 12~ . The elution profile for the hyaluronic acid, as revealed by the Folin reactivity of the bound proteins, was essentially the same as that observed for a direct papain digest of nasal Al, Fig. 4b For chondroitinase digestion of Al, the chondroitin sulfate, which is a better substrate for the enzyme (lo), must be almost completely digested before much digestion of hyaluronic acid can occur. The protein portions of the various molecules bound to the hyaluronic acid in the aggregates probably prevent access of the enzymes to the hyaluronic acid and protect relatively large lengths from digestion. The fact that mild proteolysis leaves some of these proteins still bound to hyaluronic acid provides a convenient marker for determining differences in the relative sizes of the hyaluronic acid molecules.
DISCUSSION
The column analyses of the chondroitinase digests of Al-Dl, Fig. 11, a and In the aggregates, then, it is possible that the domains of adjacent proteoglycans along the hyaluronic acid overlap somewhat in solution. Indeed, electron microscopic pictures of nasal Al (32) suggest that the proteoglycans are packed closely together in the aggregates. The link proteins in the Al-D4 fraction may stabilize the aggregates through interactions with hyaluronic acid and wit,h the proteoglycans, or they may be required to obtain a regular spacing between the proteoglycans along the hyaluronic acid chain. Their presence, however, seems necessary for the structure of the aggregate (5, 26, 27 
